Skip to main content

Closed

ARTL: Artelo Biosciences, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-158.5%

Financially safe

Stretched

Debt / equity0.11×

Interest coverage-17.1×

Current ratio1.79×

Artelo Biosciences, Inc.

ARTLNASDAQ Capital Market·USD·Closed

Artelo Biosciences, Inc.

ARTLNASDAQ·USD·Closed

$0.77

+1.96%

$0.77

+$0.01 (1.96%)

52W Range

0thpctl

Volume

0.11×avg

Mkt Cap

1.80MUSD

P/E

-0.1TTM

Div Yield

–ann

52W Range

0thpctl

Volume

0.11×avg

Market Cap

1.80MUSD

P/E Ratio

-0.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings